Skip to main content

Effects of Growth Hormone on Muscle Mass and Function

  • Chapter
Book cover Growth Hormone

Part of the book series: Endocrine Updates ((ENDO,volume 4))

  • 198 Accesses

Abstract

The anabolic nature of growth hormone (GH) is dramatically exhibited by patients with acromegaly, and indirectly by patients with GH-deficiency. A large number of in vitro and animal studies for several decades has documented stimulating effects of GH on skeletal muscle growth (1). The methods employed to document in vivo effects of GH on muscle mass in humans have been exhaustive including whole body retention of nitrogen and potassium, total and regional muscle protein metabolism using labeled amino acids, estimation of lean body mass by total body potassium or dual x-ray absorptiometry (DEXA), and direct calcualtion of muscle area or volume by computerised tomography (CT) and magnetic resonance imaging (MRI).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cheek DB. Effect of growth hormone on cell and somatic growth. In: Handbook of physiology (Eds Knobil and Sawyer) Washington DC 1974, pp 159–186

    Google Scholar 

  2. Raben M. Growth hormone. N Engl J Med 1962;266:31–35

    Article  PubMed  CAS  Google Scholar 

  3. Tanner JM, Hughes PCR, Whitehouse RH. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol 1977;84:681–696

    PubMed  CAS  Google Scholar 

  4. Korner A. Growth hormone control of biosynthesis of protein and ribonucleic acid. Recent Progr Horm Res 1965;21:205–240

    PubMed  CAS  Google Scholar 

  5. Goldberg AL. Protein turnover in skeletal muscle. The Journal of Biological Chemistry 1969;244:3217–3222

    PubMed  CAS  Google Scholar 

  6. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of Prednisone in humans. J Clin Invest 1990;86:265–272

    Article  PubMed  CAS  Google Scholar 

  7. Russell-Jones Dl, Weissberger Aj, Bowes Sb, Kelly JM, Thomason M, Umpleby AM, Jones RH, Sönksen PH. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol 1993;38:427–431

    Article  CAS  Google Scholar 

  8. Fryburg D, Barret EJ. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 1993;42:1223–1227

    Article  PubMed  CAS  Google Scholar 

  9. Copeland KC, Nair KS. Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 1994;78:1040–1047

    Article  PubMed  CAS  Google Scholar 

  10. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates foreearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499–E504

    PubMed  CAS  Google Scholar 

  11. Kelly PA, Dijane J, Postel-Vinay M-C, Edery M. The prolactin/growth hormone receptor family. Endocr Rev 1991;12:235–251

    Article  PubMed  CAS  Google Scholar 

  12. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor-I on lucose, lipid, and leucine metabolism m man. J Clin Endocnnol Metab 1992;75:1186–1191

    Article  CAS  Google Scholar 

  13. Russell-Jones DL, Umpleby AM, Hennesy TR, Bowes SB, Hopkins KD, Jackson NC, Kelly JM, Jones RH, Sonksen PH. Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 1994;267:E591–E598

    PubMed  CAS  Google Scholar 

  14. Fryburg DA, Jahn LA, Hill SA, Oliveras DM, Barrett EJ. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J Clin Invest 1995;96:1722–1729

    Article  PubMed  CAS  Google Scholar 

  15. Fryburg DA, Louard RJ, Gerow KE, Gelfano RA, Barrett EJ. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin’s antiproteolytic action in humans. Diabetes 1992;41:424–429

    Article  PubMed  CAS  Google Scholar 

  16. Copeland KC, Nair KS. Recombinant human insulin-like growth factor-I increases forearm blood flow. J Clin Endocrinol Metab 1994;79:230–232

    Article  PubMed  CAS  Google Scholar 

  17. Fryburg D. Ng-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I. J Clin Invest 1996;97:1319–1328

    Article  PubMed  CAS  Google Scholar 

  18. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Mühlen A, Fröhlich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 1996;98:2706–2713

    Article  PubMed  Google Scholar 

  19. Zurio F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990;86:1423–1427

    Article  Google Scholar 

  20. Cuneo RC, Salomon F, Sönksen PH. The syndrome of growth hormone deficiency in adults. In: Growth hormone in adults (Eds. Juul and Jørgensen), Cambridge University Press 1996.pp 145-168

    Google Scholar 

  21. De Boer H, Blok G-J, Van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63–86

    Article  PubMed  Google Scholar 

  22. Davies JS, Bell W, Evans W, Villis RJ, Scanion MF. Body composition derived from whole body counting of potassium in growth hormonedeficient adults: a possible low intracellular potasssium concentration. J Clin Endocrinol Metab 1996;81:1720–1723

    Article  PubMed  CAS  Google Scholar 

  23. Binnerts A, Deurenberg P, Swart GR, Wilson JHP, Lamberts SWJ. Body composition in growth hormone-deficient adults. Am J Clin Nutr 1992;55:918–923

    PubMed  CAS  Google Scholar 

  24. Hoffinan DM, O’Sullivan AJ, Freund J, Ho KKY. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995;80:72–77

    Article  Google Scholar 

  25. Beshyah SA, Freeemantle C, Thomas E, Rutherford O, Page B, Murphy M, Johnston DG. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol 1995;42:179–189

    Article  CAS  Google Scholar 

  26. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Møller J, Müller J, Skakkebæk NE, Christiansen JS. Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol 1991;125:449–453

    PubMed  Google Scholar 

  27. Jørgensen JOL, Thuesen L, Müller J, Ovesen P, Skakkebæk NE, Christiansen JS. Three years growth hormone treatment in growth hormone deficient adults European Journal of Endocrinology 1994;130:224–228

    Article  Google Scholar 

  28. De Boer H, Blok GJ, Voerman HJ, De Vriess PMJM, Van Der Veen EA. Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 1992;75:833–837

    Article  PubMed  Google Scholar 

  29. Hansen TB, Vahl N, Jørgensen JOL, Christiansen JS, Hagen C. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double blind, placebocontrolled study. Clin Endocrinol 1995;43:689–696

    Article  CAS  Google Scholar 

  30. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebsæk NE, Christiansen JSC. Beneficial Effects of growth hormone treatment in GH deficient adults. Lancet 1989;i:1221–1225.

    Article  Google Scholar 

  31. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone-deficient adults.I. Effects on muscle mass and strength. J Appl Physiol 1991;70:688–694

    PubMed  CAS  Google Scholar 

  32. Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB, Haden DR. Growth hormone treatment of adults with growth hormone deficiency:results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45–52

    Article  CAS  Google Scholar 

  33. Jørgensen JOL, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS. Growth hormone versus placebo treatment for one year in growth hormone deficient adults:increase in exercise capacity and normalization of body composition. Clin Endocrinol 1996;45:681–688

    Article  Google Scholar 

  34. Bengtsson B-Å, Edén S, Lönn L et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309–317

    Article  PubMed  CAS  Google Scholar 

  35. Møller J, Jørgensen JOL, Møller N, Stødkilde-Jørgensen H, Christiansen JS. Assessment of fat and muscle volume and water content by magnetic resonance imaging (MRI) and proton spectroscopy in growth hormone (GH) deficient adults before and after GH treatment Endocrinology and Metabolism 1994;1:131–135

    Google Scholar 

  36. Cuneo RC, Salomon F, Wiles CM, Round JM, Jones D, Hesp R, Sönksen RH. Histology of skeletal muscle in adults with GH deficiencyxomparison with normal muscle and response to GH treatment. Horm Res 1992;37:23–28

    Article  PubMed  CAS  Google Scholar 

  37. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone-deficient adults.II. Effects on exercise performance. J Appl Physiol 1991;70:695–700

    PubMed  CAS  Google Scholar 

  38. Caidahl K, Edén S, Bengtsson B-Å. Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994;40:393–400

    Article  CAS  Google Scholar 

  39. Beshyah SA, Freeemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston D. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol 1995;42:73–84

    Article  CAS  Google Scholar 

  40. Degerblad M, Ahnkvist O, Grunditz Hall K, Kaijser L, Knutsson E, Ringertz H, Thorén M. Physical and psychological capabilities during substitution therpay with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol 1990;123:185–193

    PubMed  CAS  Google Scholar 

  41. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming A, Bain R. Impaired growth hormone secretion in the adult population. J Clin Invest 1981;67:1361–1369

    Article  PubMed  CAS  Google Scholar 

  42. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20–39

    PubMed  CAS  Google Scholar 

  43. Yarasheski KE, Campbell JA, Smith K, Rennie MJ, Holloszy JO, Bier DM. Effects of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992;262:E261-E267

    PubMed  CAS  Google Scholar 

  44. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995;268:E268–E276

    PubMed  CAS  Google Scholar 

  45. Taafe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffinan AR, Marcus R. Effect of recombinant human growth hormone on the muscle stregth response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994;79:1361–1366

    Article  Google Scholar 

  46. Papadakis MA, Grady D, Black D, Tierny MJ, Gooding GAW, Schamblean M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708–716

    PubMed  CAS  Google Scholar 

  47. Waters D, Danska J, Hardy K, Koster F, Quails C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D. Recombinant human growth hormone, insuin-like growth factor I, and combination therapy in AIDS-associated wasting. Ann Intern Med 1996;125:865–872

    PubMed  CAS  Google Scholar 

  48. Schamblean M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HlV-associated wasting. Ann Intern Med 1996;125:873–882

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jørgensen, J.O.L., Dall, R., Vahl, N., Nørrelund, H., Christiansen, J.S. (1999). Effects of Growth Hormone on Muscle Mass and Function. In: Bengtsson, BÅ. (eds) Growth Hormone. Endocrine Updates, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5163-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5163-8_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7351-3

  • Online ISBN: 978-1-4615-5163-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics